Abstract
AIM—To evaluate the efficacy of amniotic membrane transplantation (AMT) for the management of conjunctival malignant melanoma and primary acquired melanosis (PAM) with atypia. METHODS—Four consecutive patients with histologically proved invasive, primary conjunctival malignant melanoma were treated with wide surgical excision and AMT. Amniotic membrane grafts were harvested and processed under sterile conditions according to a standard protocol. The grafts were sutured to the margins of the surface defect. In one case, AMT was combined with a corneoscleral graft. RESULTS—A satisfactory result and rapid postoperative recovery with few, transient side effects was noted in three patients with limbal/epibulbar melanomas. In another patient with an extensive lesion, involving the epibulbar, forniceal, and palpebral conjunctiva, AMT following wide excision was complicated by symblepharon formation and restricted ocular motility. Monitoring of local recurrence was facilitated by the transparency of the thin graft in all cases. The postoperative follow up time varied between several months and 3 years. In one case, local recurrence of PAM was observed and treated using topical mitomycin. CONCLUSIONS—AMT is a useful technique for the reconstruction of both small and large surface defects that result from the surgical excision of conjunctival malignant melanoma and PAM. This method facilitates wide conjunctivectomy, although its role in repairing larger defects involving the fornix or palpebral conjunctiva still needs to be established. The transparency of amniotic membrane allows for monitoring of tumour recurrence, which is—together with superior cosmesis—an advantage over thicker (for example, buccal) mucous membrane grafts.
Full Text
The Full Text of this article is available as a PDF (170.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Azuara-Blanco A., Pillai C. T., Dua H. S. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol. 1999 Apr;83(4):399–402. doi: 10.1136/bjo.83.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Demirci H., McCormick S. A., Finger P. T. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol. 2000 Jul;118(7):885–891. [PubMed] [Google Scholar]
- Dua H. S., Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999 Jun;83(6):748–752. doi: 10.1136/bjo.83.6.748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee S. H., Tseng S. C. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997 Mar;123(3):303–312. doi: 10.1016/s0002-9394(14)70125-4. [DOI] [PubMed] [Google Scholar]
- Paridaens A. D., McCartney A. C., Hungerford J. L. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol. 1992 Mar;76(3):163–165. doi: 10.1136/bjo.76.3.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paridaens A. D., McCartney A. C., Minassian D. C., Hungerford J. L. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol. 1994 Jul;78(7):520–528. doi: 10.1136/bjo.78.7.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prabhasawat P., Barton K., Burkett G., Tseng S. C. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997 Jun;104(6):974–985. doi: 10.1016/s0161-6420(97)30197-3. [DOI] [PubMed] [Google Scholar]
- Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998 Jan-Feb;42(4):321–350. doi: 10.1016/s0039-6257(97)00122-7. [DOI] [PubMed] [Google Scholar]
- Tseng S. C., Prabhasawat P., Lee S. H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997 Dec;124(6):765–774. doi: 10.1016/s0002-9394(14)71693-9. [DOI] [PubMed] [Google Scholar]